Bruno M. L. Giannetti

MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany.

Verigen specializes in tissue engineering. Its cartilage repair technology involves harvesting knee cartilage cells that are cultivated in a laboratory before being transplanted into the knee. The operation is invasive and shorter than conventional treatment, with concomitant cost savings and outcomes

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

Part of hVIVO PLC, CRM clinical trials GmbH is a German company that provides clinical research and clinical trials management services. The private company is based in Rheinbach, Germany. The company was founded by Bruno M. L. Giannetti. CRM clinical trials was acquired by Venn Life Sciences Holdings Plc on January 13, 2014 for $0.83 million.

Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries.